Cite
HARVARD Citation
Ansell, S. et al. (n.d.). INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE. Hematological oncology. pp. 177-178. [Online].